Immunocore Holdings plc

NasdaqGS:IMCR Voorraadrapport

Marktkapitalisatie: US$1.6b

Immunocore Holdings Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Bahija Jallal

Algemeen directeur

US$11.7m

Totale compensatie

Percentage CEO-salaris6.3%
Dienstverband CEO5.8yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn2.8yrs
Gemiddelde ambtstermijn bestuur5.2yrs

Recente managementupdates

Recent updates

Is Immunocore Holdings (NASDAQ:IMCR) Using Debt Sensibly?

Oct 24
Is Immunocore Holdings (NASDAQ:IMCR) Using Debt Sensibly?

Immunocore Holdings plc's (NASDAQ:IMCR) Business And Shares Still Trailing The Industry

Sep 19
Immunocore Holdings plc's (NASDAQ:IMCR) Business And Shares Still Trailing The Industry

Immunocore Holdings: KIMMTRAK Success, Diverse Pipeline, And Potential Big Pharma Appeal

Aug 12

Is Immunocore Holdings plc (NASDAQ:IMCR) Trading At A 33% Discount?

Jul 24
Is Immunocore Holdings plc (NASDAQ:IMCR) Trading At A 33% Discount?

Immunocore Holdings plc's (NASDAQ:IMCR) 28% Dip In Price Shows Sentiment Is Matching Revenues

Jun 16
Immunocore Holdings plc's (NASDAQ:IMCR) 28% Dip In Price Shows Sentiment Is Matching Revenues

Is Immunocore Holdings (NASDAQ:IMCR) Using Debt Sensibly?

May 11
Is Immunocore Holdings (NASDAQ:IMCR) Using Debt Sensibly?

Immunocore Holdings plc (NASDAQ:IMCR) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 11
Immunocore Holdings plc (NASDAQ:IMCR) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Are Investors Undervaluing Immunocore Holdings plc (NASDAQ:IMCR) By 25%?

Apr 05
Are Investors Undervaluing Immunocore Holdings plc (NASDAQ:IMCR) By 25%?

Here's Why Immunocore Holdings (NASDAQ:IMCR) Can Manage Its Debt Despite Losing Money

Jan 22
Here's Why Immunocore Holdings (NASDAQ:IMCR) Can Manage Its Debt Despite Losing Money

Immunocore Holdings: Vulnerable To Profit Taking After Big Rally

Jan 21

Revenues Not Telling The Story For Immunocore Holdings plc (NASDAQ:IMCR) After Shares Rise 37%

Dec 18
Revenues Not Telling The Story For Immunocore Holdings plc (NASDAQ:IMCR) After Shares Rise 37%

Some Confidence Is Lacking In Immunocore Holdings plc's (NASDAQ:IMCR) P/S

May 08
Some Confidence Is Lacking In Immunocore Holdings plc's (NASDAQ:IMCR) P/S

Forecast: Analysts Think Immunocore Holdings plc's (NASDAQ:IMCR) Business Prospects Have Improved Drastically

Nov 16
Forecast: Analysts Think Immunocore Holdings plc's (NASDAQ:IMCR) Business Prospects Have Improved Drastically

Immunocore: Attractive Commercial-Stage Biopharma

Oct 05

Need To Know: Analysts Are Much More Bullish On Immunocore Holdings plc (NASDAQ:IMCR)

Aug 12
Need To Know: Analysts Are Much More Bullish On Immunocore Holdings plc (NASDAQ:IMCR)

Immunocore GAAP EPS of -$0.17, revenue of $38.92M

Aug 10

Immunocore to raise $140M in private placement financing

Jul 18

Analyse CEO-vergoeding

Hoe is Bahija Jallal's beloning veranderd ten opzichte van Immunocore Holdings's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

-US$47m

Jun 30 2024n/an/a

-US$55m

Mar 31 2024n/an/a

-US$60m

Dec 31 2023US$12mUS$735k

-US$55m

Sep 30 2023n/an/a

-US$69m

Jun 30 2023n/an/a

-US$61m

Mar 31 2023n/an/a

-US$52m

Dec 31 2022US$1mUS$700k

-US$53m

Sep 30 2022n/an/a

-US$62m

Jun 30 2022n/an/a

-US$112m

Mar 31 2022n/an/a

-US$156m

Dec 31 2021US$35mUS$700k

-US$180m

Sep 30 2021n/an/a

-US$150m

Jun 30 2021n/an/a

-US$139m

Mar 31 2021n/an/a

-US$116m

Dec 31 2020US$1mn/a

-US$101m

Compensatie versus markt: De totale vergoeding ($USD 11.68M ) Bahija } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.54M ).

Compensatie versus inkomsten: De vergoeding van Bahija is gestegen terwijl het bedrijf verliesgevend is.

CEO

Bahija Jallal (63 yo)

5.8yrs

Tenure

US$11,678,834

Compensatie

Dr. Bahija Jallal, Ph.D. serves as Director of Outpace Bio, Inc. from March 2023. She serves as Chief Executive Officer and Director of Immunocore Holdings plc (formerly known as Immunocore Holdings Limite...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Bahija Jallal
CEO & Executive Director5.8yrsUS$11.68mgeen gegevens
Brian Di Donato
Executive VP4.6yrsUS$3.35m0.038%
$ 620.7k
Tina Leger
Chief Human Resources Officer2.8yrsUS$1.04mgeen gegevens
David Berman
Executive Vice President of Research & Development5.8yrsUS$4.40m0%
$ 0
John Trainer
SVP & Chief Operating Officerless than a yeargeen gegevensgeen gegevens
John Goll
SVP, Finance & Chief Accounting Officerless than a yeargeen gegevensgeen gegevens
Annelise Vuidepot
Senior VPno datageen gegevensgeen gegevens
Sean Buckley
VP & Chief Information Officerless than a yeargeen gegevensgeen gegevens
Clayton Robertson
Head of Investor Relationsno datageen gegevensgeen gegevens
Lily Hepworth
Senior VP3.8yrsgeen gegevensgeen gegevens
Elizabeth Jobes
Chief Compliance Officerless than a yeargeen gegevensgeen gegevens
Sébastien Desprez
Vice President of Communications2.8yrsgeen gegevensgeen gegevens

2.8yrs

Gemiddelde duur

54.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van IMCR wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.8 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Bahija Jallal
CEO & Executive Director5.8yrsUS$11.68mgeen gegevens
John Bell
Independent Non-Executive Chairman9.7yrsUS$416.99k0.027%
$ 434.3k
Kristine Peterson
Independent Non-Executive Director7yrsUS$389.49k0%
$ 0
Robert Perez
Independent Non-Executive Director5.2yrsgeen gegevensgeen gegevens
Roy Steven Herbst
Independent Non-Executive Director3.8yrsUS$386.99k0%
$ 0
Peter Ratcliffe
Independent Non-Executive Director4yrsUS$384.49k0.00067%
$ 10.8k
Ranjeev Krishana
Directorless than a yeargeen gegevensgeen gegevens
Travis Coy
Independent Non-Executive Director5.2yrsgeen gegevensgeen gegevens
Siddharth Kaul
Independent Non-Executive Director2.4yrsUS$386.99k0%
$ 0

5.2yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van IMCR wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.2 jaar).